KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Idexx Laboratories (IDXX) Operating Expenses (2016 - 2025)

Idexx Laboratories (IDXX) has 17 years of Operating Expenses data on record, last reported at $342.5 million in Q4 2025.

  • For Q4 2025, Operating Expenses rose 10.85% year-over-year to $342.5 million; the TTM value through Dec 2025 reached $1.3 billion, up 3.91%, while the annual FY2025 figure was $1.3 billion, 3.91% up from the prior year.
  • Operating Expenses reached $342.5 million in Q4 2025 per IDXX's latest filing, up from $328.5 million in the prior quarter.
  • Across five years, Operating Expenses topped out at $355.4 million in Q2 2024 and bottomed at $108.3 million in Q1 2021.
  • Average Operating Expenses over 5 years is $206.4 million, with a median of $137.9 million recorded in 2023.
  • Peak YoY movement for Operating Expenses: tumbled 33.48% in 2023, then soared 160.96% in 2024.
  • A 5-year view of Operating Expenses shows it stood at $128.8 million in 2021, then decreased by 1.79% to $126.5 million in 2022, then increased by 9.78% to $138.8 million in 2023, then soared by 122.55% to $309.0 million in 2024, then rose by 10.85% to $342.5 million in 2025.
  • Per Business Quant database, its latest 3 readings for Operating Expenses were $342.5 million in Q4 2025, $328.5 million in Q3 2025, and $321.7 million in Q2 2025.